---
schema_version: "secwatch.filing_event.v1"
accession: "0000950103-24-006462"
form_type: "8-K"
ticker: "ADCT"
cik: "0001771910"
company_name: "ADC Therapeutics SA"
filed_at: "2024-05-08T23:59:59+00:00"
generated_at: "2026-06-02T12:08:51.571255+00:00"
event_type: "other_material"
sentiment: "neutral"
materiality_score: 0.6
calibrated_materiality_score: 0.6
confidence: "high"
source: SEC EDGAR
---

# ADC Therapeutics raises ~$105M in public offering of common shares and pre-funded warrants

## Summary
- Offered 13.4M common shares at $4.90/share and pre-funded warrants for 8.2M shares at $4.812/warrant.
- Gross proceeds ~$105M; underwriters include Jefferies, Guggenheim, Cantor Fitzgerald; offering closed May 8, 2024.
- Pre-funded warrants exercisable at CHF 0.08/share, with a 9.99% beneficial ownership cap (adjustable to 19.99%).
- Warrants have a 10-year term and may be exercised on a cashless basis under certain conditions.

## SEC filing metadata
- accession: 0000950103-24-006462
- form_type: 8-K
- ticker: ADCT
- cik: 0001771910
- company_name: ADC Therapeutics SA
- filed_at: 2024-05-08T23:59:59+00:00
- event_type: other_material
- sentiment: neutral
- materiality_score: 0.6
- calibrated_materiality_score: 0.6
- confidence: high
- sec_items: 8.01, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1771910/000095010324006462/0000950103-24-006462-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1771910/000095010324006462/dp210968_8k.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0000950103-24-006462
- JSON: https://secwatch.observer/filing/0000950103-24-006462.json
- Plain text: https://secwatch.observer/filing/0000950103-24-006462.txt

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.